Logos Global Management LP 13D and 13G filings for Aligos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:32 pm Sale |
2021-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
Logos Global Management LP | 0 0.000% |
-114,911 (Position Closed) |
Filing |
| 2021-08-13 12:27 pm Purchase |
2021-08-03 | 13G | Aligos Therapeutics, Inc. ALGS |
Logos Global Management LP | 114,911 6.700% |
114,911 (New Position) |
Filing |